ask="2.20"
ask_size="100"
average_daily_volume="322197"
bid="1.98"
bid_size="5000"
book_value="0.44"
change="-0.07"
change_from_200_day_moving_average="0.11"
change_from_50_day_moving_average="0.13"
change_from_52_week_high="-1.03"
change_From_52_week_low="1.19"
change_in_percent="-3.37%"
close="2.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.99"
ex_dividend_date="N/A"
float_shares="21469000"
high="2.20"
high_52_weeks="3.04"
last_trade_date="2/2/2017"
last_trade_price="2.01"
last_trade_size="18386"
last_trade_time="4:00pm"
low="1.83"
low_52_weeks="0.82"
market_capitalization="47.13M"
moving_average_200_day="1.90"
moving_average_50_day="1.88"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="7.63"
open="1.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.76%"
percent_change_from_50_day_moving_average="+7.09%"
percent_change_from_52_week_high="-33.88%"
percent_change_from_52_week_low="+145.09%"
previous_close="2.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.86"
stock_exchange="NCM"
symbol="CBAY"
volume="1357902"
weeks_range_52="0.82 - 3.04"
